by
Aine Cryts, Contributing Reporter | September 11, 2015
“Many physicians are just going to wear out, as insurance companies bring them through this machinery and deny access to those off-label therapies. This is truly life altering for patients in a direct way,” she said.
Some industry analysts, such as Marianne Udow-Phillips, director of the Center for Healthcare Research and Transformation at the University of Michigan, have come out in support of the proposed mergers.
Ad Statistics
Times Displayed: 113248
Times Visited: 6741 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Udow-Phillips
told USA Today that the mergers could drive down the cost of health care by giving insurance companies increased leverage to negotiate with care providers.
Another supporter of the mergers is Jon Kaplan, senior partner with the Boston Consulting Group. “There is little doubt consolidation will give insurers greater bargaining power with which to negotiate better rates with providers. It will also reduce administrative overhead. Aetna estimates, for example, that the Humana merger could produce approximately $1.25 billion in annual cost savings by 2018,”
wrote Kaplan on CNBC.com.
Back to HCB News
